BMS wins European Evotaz approval; AMRI buys Gadea for $174M;

@FiercePharma: PetCure Spots Booming Market For Radiosurgery in Pets With Cancer. FierceAnimalHealth article | Follow @FiercePharma

@CarlyHFierce: Endo whistleblower nabs $33.6M from feds for 'extraordinary' work in FCA suit. Story | Follow @CarlyHFierce

> The European Commission (EC) has approved Bristol-Myers Squibb's ($BMY) Evotaz in combination with other antiretroviral agents for the treatment of HIV-1. Report

> AMRI ($AMRI) has purchased Spain's Gadea Pharmaceutical Group for $174 million. Report

> Pfizer ($PFE) has agreed to hand over email chains between its expert witness in the Zoloft multi-district litigation and authors of studies on the risks of the med. Report

Medical Device News

@FierceMedDev: Illumina launches new lab service for HiSeq X sequencing systems. Story | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Malaysian government approves 11 med tech projects worth $120M+. Report | Follow @VarunSaxena2

@EmilyWFierce: Cardiologists weigh in on #FDA's device oversight and 21st Century Cures Act. NYT story | Follow @EmilyWFierce

> EU funds development of a photonic-laser point-of-care cancer Dx device. More

> FDA approves the first implantable, above-the-knee prosthesis. Story

Biotech News

@FierceBiotech: Singapore's big biotech push yields its first clinical contender. Story | Follow @FierceBiotech

@JohnCFierce: Interesting data points coming up on Alzheimer's, a field that makes giddy enthusiasts out of virtually all biz journalists. #odd | Follow @JohnCFierce

> Pint-sized biotechs join the IPO queue as Wall Street cash pours in. More

> Torrid pace of VC investing in H1 sets a new biotech record. News

> Lilly and Biogen prep make-or-break Alzheimer's data amid an amyloid renaissance. Article

And Finally... Wild starlings are ingesting worms that have taken in chemicals from Prozac--and it's changing their behavior. More